All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Deghor 120mg Injection
Prescription Required
Salt Composition : Degarelix
Manufacturer : GLENMARK PHARMACEUTICALS LTD
Origin of Medicine : India
1 Vial(s)
Introduction to Deghor 120mg Injection
Deghor 120mg injection contains the active ingredient degarelix. It is used to treat advanced prostate cancer. Prostate cancer is cancer that occurs in the prostate (a gland in males that produces seminal fluid). Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.Â
Contact your doctor immediately if you experience dizziness, fever, or infection. During this treatment, your doctor may periodically monitor your blood pressure, blood sugar, electrolytes, heart, liver, and kidney parameters to prevent serious complications. Report to your doctor if you have been diagnosed with problems in your heart, liver, or kidneys. Patients with severe liver and kidney impairment should exercise caution while using this medicine. This medicine is contraindicated in patients with known hypersensitivity to this drug or to any of the product components.
Deghor 120mg injection has the potential to impair the fertility of males and females of reproductive potential. This injection is not recommended during pregnancy due to its ability to harm the foetus and cause miscarriage. It is not known if this medicine passes into breast milk. Consult your doctor for more advice. Possible side effects related to therapy include redness, swelling, and itching at the injection site. These are usually mild, self-limiting, and decrease within three days.
Uses of Deghor 120mg Injection
- Advanced prostate cancer
Therapeutic Effects of Deghor 120mg Injection
Degarelix directly blocks the effects of a natural hormone (gonadotropin-releasing hormone, GnRH), reduces the level of the male hormone testosterone, and slows down the growth of prostate cancer cells.
Interaction of Deghor 120mg Injection with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Deghor 120mg injection and reduce effectiveness by causing undesirable side effects.Â
More Information about Deghor 120mg Injection
- Store Deghor 120mg injection in a refrigerator (2°C – 8°C).
- Do not freeze.
- Keep it out of reach from children and pets.
How to consume Deghor 120mg Injection
Deghor 120mg injection is available as a prefilled syringe and solution for injection. Your doctor or nurse will administer the injection into the fatty tissues just under your skin (subcutaneously). The dose, route of administration, and frequency will be decided by your doctor based on your disease condition and other factors.
Safety Advices for Deghor 120mg Injection
 Â
Pregnancy
 Â
Deghor 120mg injection is unsafe when administered during pregnancy because it may cause birth defects in your baby. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
 Â
Breast Feeding
 Â
It is not known whether Deghor 120mg injection passes into the breastmilk. Consult your doctor for more advice.
 Â
Lungs
  It is unknown whether Deghor 120mg injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
 Â
Liver
  It is unknown whether Deghor 120mg injection can be administered in patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with this injection.
 Â
Alcohol
 ÂIt is unsafe to consume alcohol with Deghor 120mg injection. Please consult your doctor for more advice.
 Â
Driving
  It is unsafe to travel, drive vehicles, or operate heavy machinery after taking (1 hour) Deghor 120mg injection. Please consult your doctor.
Side Effects of Deghor 120mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.Â
Common
- Hot flashes
- Injection site reactions (redness and pain)
- Fever, chills
- Headache, dizziness
- Trouble sleeping
- Tiredness
- Nausea, diarrhea
- Increased weight
- Excessive sweating (including night sweats)
- Anemia
- Muscle pain and discomfort
- Breast swelling, reduced size of testicles
- Decreased sex drive
Word of Advice
Deghor 120mg injection can cause hot flashes, hence it is advised to wear loose-fitting clothes to avoid discomfort. Eat a well-balanced diet. If you feel dizzy or tired, avoid driving or handling machines. Do not touch or rub your skin after injecting this medicine.
FAQs
Q 1. Is Deghor 120mg injection used as a monotherapy to treat cancer?
Deghor 120mg injection is prescribed alone and also with other anti-androgen medications to treat hormonal cancer.
Q 2. Is it safe to use Deghor 120mg injection during pregnancy?
Deghor 120mg injection can harm an unborn baby and result in miscarriage. Hence it is not recommended during pregnancy.
Q 3. How is Deghor 120mg injection administered?
Deghor 120mg injection is administered as a subcutaneous injection (under the skin), usually in the lower abdomen, once every 28 days.
Q 4. What are the common side effects of Deghor 120mg injection?
Injection site reactions, weight gain, chills, hot flashes, hypertension, asthenia, tiredness, fever, constipation, back pain, urinary tract infection, changes in liver enzymes, dizziness, headache, and insomnia are the most common side effects of Deghor 120mg injection.
Q 5. Who should not take Deghor 120mg injection?
Deghor 120mg injection is not recommended for men who have a history of severe allergic reactions to the medication.
Fact Box of Deghor 120mg Injection
Molecule name: Degarelix  | Therapeutic class: Antineoplastics |
Pharmacological class: Gonadotropin-releasing hormone antagonists | Indications:Â Advanced prostate cancer |
References
- Ferring Pharmaceuticals A/S, Electronic medicines compendium (EMC), [ Revised on Dec 2019] [ Accessed on 23rd March 2023], https://www.medicines.org.uk/emc/files/pil.6537.pdf
- Ferring Pharmaceuticals Inc, US Food and Drug Administration, [ Revised on Feb 2015] [ Accessed on 23rd March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022201s009lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Natural products in cancer chemotherapy: Hormones and related agents, 12th edition, 2011, 1764.
- Claudine Isaacs, Anton Wellstein, and Anna T. Riegel, Hormones and Related Agents in the Therapy of Cancer, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1237-1247.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
